| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |